These findings suggest that estrogens may exert anti-CRC effects by enhancing certain probiotics intestinal colonization, increasing the abundance of SCFAs-producing bacteria, or altering the composition of the intestinal flora through ERβ-mediated pathways (Fig. 3c). Here, ESR2 is linked to colorectal carcinoma.